NFE2L2 and Schnyder corneal dystrophy: Notably, genetic evidence has shown that Nrf2 activation can specifically mitigate the severity of hemolytic anemia and systemic and local inflammation in transgenic SCD mice via suppressing the pro-inflammatory response and reducing reactive oxygen species (ROS) stress [34,35].